Scarica l'app Stockscreener
5.08
5.22%
-0.28
Dopo l'orario di chiusura:
5.08
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Precedente Chiudi:
$5.36
Aprire:
$5.39
Volume 24 ore:
1.84M
Relative Volume:
1.08
Capitalizzazione di mercato:
$275.29M
Reddito:
-
Utile/perdita netta:
$-54.19M
Rapporto P/E:
-1.969
EPS:
-2.58
Flusso di cassa netto:
$-37.34M
1 W Prestazione:
-0.97%
1M Prestazione:
+14.16%
6M Prestazione:
-17.53%
1 anno Prestazione:
-13.75%
Intervallo 1D:
$5.00
$5.39
Intervallo di 1 settimana:
$5.00
$5.605
Portata 52W:
$3.9328
$7.5401
Abeona Therapeutics Inc Stock (ABEO) Company Profile
Nome
Abeona Therapeutics Inc
Settore
Industria
Telefono
646-813-4701
Indirizzo
6555 CARNEGIE AVE, 4TH FLOOR, CLEVELAND, NY
Confronta ABEO con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
ABEO
Abeona Therapeutics Inc
|
5.08 | 290.47M | 0 | -54.19M | -37.34M | -2.58 |
|
VRTX
Vertex Pharmaceuticals Inc
|
455.71 | 114.69B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
752.62 | 77.91B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ARGX
Argen X Se Adr
|
850.95 | 54.05B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
391.50 | 52.52B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
INSM
Insmed Inc
|
196.92 | 42.02B | 447.02M | -1.18B | -906.14M | -6.1812 |
Abeona Therapeutics Inc Stock (ABEO) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-06-02 | Ripresa | Oppenheimer | Outperform |
| 2025-03-05 | Iniziato | Oppenheimer | Outperform |
| 2024-07-03 | Iniziato | H.C. Wainwright | Buy |
| 2024-05-30 | Iniziato | Stifel | Buy |
| 2020-11-11 | Aggiornamento | Cantor Fitzgerald | Neutral → Overweight |
| 2020-09-18 | Iniziato | B. Riley FBR | Buy |
| 2020-02-10 | Iniziato | SVB Leerink | Outperform |
| 2019-12-10 | Ripresa | Cantor Fitzgerald | Neutral |
| 2019-08-15 | Downgrade | Maxim Group | Buy → Hold |
| 2019-08-12 | Downgrade | Cantor Fitzgerald | Overweight → Neutral |
| 2019-07-26 | Downgrade | Mizuho | Buy → Neutral |
| 2019-06-27 | Iniziato | Mizuho | Buy |
| 2018-10-12 | Iniziato | Mizuho | Buy |
| 2018-06-05 | Iniziato | Seaport Global Securities | Buy |
| 2017-11-08 | Iniziato | SunTrust | Buy |
| 2017-10-16 | Reiterato | H.C. Wainwright | Buy |
| 2017-10-11 | Reiterato | Cantor Fitzgerald | Overweight |
| 2017-10-10 | Iniziato | Citigroup | Buy |
| 2017-10-05 | Reiterato | Maxim Group | Buy |
| 2017-09-15 | Iniziato | RBC Capital Mkts | Outperform |
| 2017-07-18 | Reiterato | Maxim Group | Buy |
| 2017-06-22 | Ripresa | Jefferies | Buy |
| 2017-01-06 | Iniziato | Jefferies | Buy |
| 2016-09-29 | Reiterato | Maxim Group | Buy |
Mostra tutto
Abeona Therapeutics Inc Borsa (ABEO) Ultime notizie
Abeona Therapeutics appoints Mohamad Tabrizi as chief business officer - Investing.com
Abeona Therapeutics names Mohamad Tabrizi as chief business officer - marketscreener.com
Abeona Therapeutics appoints Mohamad Tabrizi as chief business officer By Investing.com - Investing.com Canada
Abeona Therapeutics Appoints Mohamad Tabrizi as Senior Vice President, Chief Business Officer - Quiver Quantitative
Abeona Therapeutics® Announces Appointment of Mohamad Tabrizi as Chief Business Officer - GlobeNewswire
(ABEO) Risk Channels and Responsive Allocation - news.stocktradersdaily.com
AWM Investment Company Inc. Acquires New Shares in Abeona Therapeutics Inc. $ABEO - MarketBeat
Boone Capital Management LLC Makes New Investment in Abeona Therapeutics Inc. $ABEO - MarketBeat
Abeona Therapeutics (NASDAQ:ABEO) Share Price Passes Below Two Hundred Day Moving AverageTime to Sell? - MarketBeat
Abeona Therapeutics (ABEO) Expands Zevaskyn Treatment Access in Texas - GuruFocus
Abeona Therapeutics Activates New Qualified Treatment Center for ZEVASKYN in Texas - Quiver Quantitative
Abeona Therapeutics (Nasdaq: ABEO) designates UTMB as new ZEVASKYN gene therapy treatment center in Texas - Stock Titan
Is Abeona Therapeutics Inc a good long term investment - earlytimes.in
Abeona Therapeutics (ABEO) Begins First Commercial Use of ZEVASK - GuruFocus
Abeona Therapeutics® Announces First Patient Treatment with ZEVASKYN® Gene Therapy - The Manila Times
Abeona Therapeutics Announces First Commercial Patient Treatment with FDA-Approved ZEVASKYN for Recessive Dystrophic Epidermolysis Bullosa - Quiver Quantitative
Abeona Therapeutics (Nasdaq: ABEO) begins commercial use of FDA-approved ZEVASKYN for RDEB - Stock Titan
Is Abeona Therapeutics Stock Built to Withstand a Pullback? - Trefis
Abeona Therapeutics Inc. (NASDAQ:ABEO) Receives Consensus Rating of "Moderate Buy" from Analysts - MarketBeat
What makes Abeona Therapeutics Inc. stock attractive to growth funds2025 Performance Recap & Reliable Intraday Trade Plans - Newser
Will Abeona Therapeutics Inc. stock see PE expansionSell Signal & Free Weekly Chart Analysis and Trade Guides - Newser
Can Abeona Therapeutics Inc. (PCJ) stock survive global slowdownJuly 2025 Institutional & Verified Trade Idea Suggestions - Newser
How forex fluctuations impact Abeona Therapeutics Inc. (PCJ) stockMarket Growth Summary & Expert Curated Trade Ideas - Newser
How strong is Abeona Therapeutics Inc. stock balance sheetVolume Spike & Community Trade Idea Sharing - Newser
Abeona Therapeutics (ABEO) Stock Analysis Report | Financials & Insights - Benzinga
Why retail traders accumulate Abeona Therapeutics Inc. (PCJ) stockMarket Sentiment Summary & AI Optimized Trading Strategy Guides - Newser
Can Abeona Therapeutics Inc. (PCJ) stock sustain revenue momentumJuly 2025 WrapUp & Real-Time Volume Trigger Notifications - Newser
What downside risks could hit Abeona Therapeutics Inc. (PCJ) stockPortfolio Gains Summary & Technical Confirmation Trade Alerts - Newser
Published on: 2025-12-02 01:12:50 - Newser
Abeona Therapeutics (ABEO) Distributes Equity Awards to New Empl - GuruFocus
Abeona announces employee inducement grants under Nasdaq rule - marketscreener.com
Abeona Therapeutics® Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewswire
ABEO FY2025 EPS Forecast Lifted by Cantor Fitzgerald - MarketBeat
Why institutional investors increase stakes in Abeona Therapeutics Inc. (PCJ) stock2025 Top Gainers & Precise Entry and Exit Recommendations - BỘ NỘI VỤ
What analysts say about Abeona Therapeutics Inc stockREITs Market Trends & Small Capital Growth Stocks - earlytimes.in
Abeona Therapeutics (NASDAQ:ABEO) Stock Price Passes Below Fifty Day Moving AverageWhat's Next? - MarketBeat
Liquidity Mapping Around (ABEO) Price Events - news.stocktradersdaily.com
Here's Why Abeona Therapeutics Popped Higher Today - MSN
What technical patterns form on Abeona Therapeutics Inc. (PCJ) stock chartsJuly 2025 Recap & High Accuracy Investment Entry Signals - newser.com
How Abeona Therapeutics Inc. (PCJ) stock behaves in tightening cyclesGold Moves & Verified Momentum Stock Alerts - newser.com
Abeona Therapeutics Earnings Call: Positive Outlook Amid Challenges - MSN
Is Abeona Therapeutics Inc. (PCJ) stock positioned for digital growth eraIPO Watch & Low Risk Investment Opportunities - newser.com
Is Abeona Therapeutics Inc. (PCJ) stock trading at attractive multiples2025 Price Momentum & Weekly High Potential Alerts - newser.com
Visualizing Abeona Therapeutics Inc. stock with heatmapsVolume Spike & Community Trade Idea Sharing - newser.com
Will Abeona Therapeutics Inc. stock benefit from green energy trendsTrade Risk Summary & Risk Controlled Stock Pick Alerts - newser.com
Sentiment analysis tools applied to Abeona Therapeutics Inc.2025 Risk Factors & AI Powered Market Entry Strategies - newser.com
FY2025 Earnings Estimate for ABEO Issued By HC Wainwright - MarketBeat
Abeona Therapeutics Inc Azioni (ABEO) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.36%
1.12%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):